Jean Jacques Bienaime
Jean Jacques Bienaime's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price and…
Insider buying and selling since 2001
Jean Jacques Bienaime bought shares on the open market in 13 different years since 2001 across 5 companies. Sales in 18 of the 26 years since 2001.
Jean Jacques Bienaime reported 57 open-market purchases and 511 sales since 2001; purchases in 13 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | 6×6 trades | — |
| 2025 | 3×3 trades | — |
| 2024 | 2×2 trades | 11×11 trades |
| 2023 | — | 18×18 trades |
| 2022 | — | 20×20 trades |
| 2021 | — | 19×19 trades |
| 2020 | — | 14×14 trades |
| 2019 | — | 34×34 trades |
| 2018 | 2×2 trades | 24×24 trades |
| 2017 | 7×7 trades | 24×24 trades |
| 2016 | — | 26×26 trades |
| 2015 | 4×4 trades | 22×22 trades |
| 2014 | 1×1 trade | 20×20 trades |
| 2013 | — | 36×36 trades |
| 2012 | — | 43×43 trades |
| 2011 | — | 18×18 trades |
| 2010 | 1×1 trade | 15×15 trades |
| 2009 | 2×2 trades | 4×4 trades |
| 2008 | 2×2 trades | 65×65 trades |
| 2007 | 2×2 trades | 98×98 trades |
| 2006 | 24×24 trades | — |
| 2001 | 1×1 trade | — |
Insider at 5 companies
- Keros Therapeutics KROS2026 · 6 purchases, 0 sales
- Immunome IMNM2024–2025 · 5 purchases, 0 sales
- BioMarin Pharmaceutical BMRN2006–2024 · 31 purchases, 506 sales
- Incyte INCY2017–2020 · 7 purchases, 3 sales
- Immunic IMUX2001–2018 · 8 purchases, 2 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Jean Jacques Bienaime's trades
Has Jean Jacques Bienaime bought shares on the open market?
Jean Jacques Bienaime bought shares on the open market in 13 different years since 2001 across 5 companies. Sales in 18 of the 26 years since 2001.
When did Jean Jacques Bienaime last buy or sell shares?
In SEC filings since 2001: the latest open-market purchase is from 2026; the latest open-market sale is from 2024.
Which companies has Jean Jacques Bienaime traded as an insider?
5 companies: Keros Therapeutics (KROS, 2026), Immunome (IMNM, 2024–2025), BioMarin Pharmaceutical (BMRN, 2006–2024), Incyte (INCY, 2017–2020), Immunic (IMUX, 2001–2018).